Category: Healthcare Finance News

American Medical Association report shows competition shrinking in many U.S. health insurance markets

Anthem was the largest insurer in more metropolitan markets than any other insurer; Health Care Service Corp. was second, followed by UnitedHealth Group.

CVS Health and Aetna merger closes

Combined company is expected to generate revenue-enhancing initiatives, though Moody’s has downgraded CVS’s rating based on the debt level from $69 billion merger.

What healthcare consumers really want: convenience, to start

Health systems can improve competitiveness by meeting consumer demand for more timely and accessible care.

Dignity Health, Catholic Health Initiatives mega-merger clears major hurdle in California, winning state DOJ approval

The CA DOJ set strong conditions for their approval which the agency meant as protection for Medi-Cal beneficiaries and charity care.

Where health execs expect to invest: revenue cycle, EHR and self-pay

Revenue cycle is an EHR-related area of dissatisfaction — 56 percent of execs said EHR RCM adoption challenges have been equal to benefits.

Top 25 healthcare supply chains in 2018, as ranked by Gartner

Cleveland Clinic came in first, and has been in the top 10 in the ranking for the past three years.

Medical University of South Carolina makes first-ever hospital acquisition with purchase of 4 hospitals from Community Health Systems

The additions will increase the size and scale of the MUSC Health network, delivering greater value to patients and positively impacting population health.

Small and medium-sized health plans represent 83 percent of market

Medicare Advantage, managed Medicaid and provider-sponsored plans, represent the bulk of the SMB market.

Healthcare jobs to surge faster than any other sector through 2026, Glassdoor says

The industry is on track to generate more than 1.1 million new jobs by 2026, spurred in part by demand for nurses.

CMS proposes giving Part D plans greater negotiating power with drug manufacturers.

CMS is proposing to give Medicare Part D drug plans flexibility to negotiate discounts for drugs in "protected" therapeutic classes.